In Brief: Condom marketing
This article was originally published in The Tan Sheet
Executive Summary
Condom marketing: FDA is making a Feb. 23, 1994 policy statement available to manufacturers, distributors and importers on the marketing of "condom-like" products, including those labeled as novelty items, that cautions that such products are subject to the regulations for medical devices, the agency announced in an Aug. 3 Federal Register notice. FDA believes that some marketers have "misinterpreted" an earlier policy statement and are marketing functional condoms as novelty items without complying with leak-testing requirements, GMPs and other requirements...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning